Knight Robert Douglas 4
4 · NexImmune, Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Knight Robert Douglas
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-11+210,609→ 210,609 totalExercise: $17.00Exp: 2025-02-11→ Common Stock (210,609 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on the first anniversary of the grant date (the "Initial Vesting Date") (2/11/2021) and 1/48 of the shares subject to the option shall vest on each month anniversary of the Initial Vesting Date such that after four (4) years, all shares subject to the option shall be vested, subject to the participant's continuous service on each such vesting date.